GlassScriptPhysician profile
David R Tano
NPI 1215294533
$399.83
in general payments reported to CMS, 2019-2025
8 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $62.67 · 2023: $37.70 · 2024: $57.08 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $118.82 | 2022-2025 | Invega Sustenna, Invega, Invega Trinza |
| Alkermes, INC. | $69.61 | 2021-2025 | Aristada, Lybalvi |
| Abbvie INC. | $56.23 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $53.44 | 2022-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $37.15 | 2023-2025 | Austedo Xr, Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $25.33 | 2024 | Cobenfy |
| Janssen Biotech, INC. | $20.71 | 2021 | |
| Neurocrine Biosciences, INC. | $18.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.